Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.

Details

Ressource 1Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: All rights reserved
Serval ID
serval:BIB_AD1904965D5E
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
Journal
Hypertension
Author(s)
Meylan S., Livio F., Foerster M., Genoud P.J., Marguet F., Wuerzner G.
Working group(s)
CHUV COVID Vaccination Center
ISSN
1524-4563 (Electronic)
ISSN-L
0194-911X
Publication state
Published
Issued date
06/2021
Peer-reviewed
Oui
Volume
77
Number
6
Pages
e56-e57
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
Keywords
Aged, Blood Pressure Determination/methods, Blood Pressure Determination/psychology, COVID-19/epidemiology, COVID-19/prevention & control, COVID-19/psychology, COVID-19 Vaccines/administration & dosage, COVID-19 Vaccines/adverse effects, Causality, Female, Humans, Hypertension/diagnosis, Hypertension/epidemiology, Hypertension/etiology, Male, Needs Assessment, Psychology, Risk Factors, SARS-CoV-2, Switzerland/epidemiology, Symptom Assessment/methods, Vaccination/methods, Vaccination/psychology, headache, humans, hypertension, vaccines, vital signs
Pubmed
Web of science
Open Access
Yes
Create date
05/04/2021 9:40
Last modification date
31/10/2023 7:09
Usage data